| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/17/2012 | US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders |
| 07/17/2012 | US8222294 Combinations of an anti emetic agent and an enkephalinase inhibitor |
| 07/17/2012 | US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/17/2012 | US8222229 Peritoneal dialysis method |
| 07/17/2012 | US8222036 Oncolytic viruses as phenotyping agents for neoplasms |
| 07/17/2012 | US8221805 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 07/17/2012 | US8221794 Anti-angiogenic nanoparticle compositions |
| 07/17/2012 | US8221771 Formulations containing an immune response modifier |
| 07/17/2012 | US8221763 Yeast-antigen compositions and methods of using the same |
| 07/17/2012 | US8221761 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifs |
| 07/17/2012 | US8221735 Embolic compositions |
| 07/17/2012 | CA2496699C Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| 07/17/2012 | CA2488373C N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 07/17/2012 | CA2451704C Fortified rice bran food product and method for promoting cardiovascular health |
| 07/17/2012 | CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof |
| 07/17/2012 | CA2322559C Compositions and methods for modulating vascularization |
| 07/12/2012 | WO2012093681A1 Method for selecting patient to be given drug for treating septicemia |
| 07/12/2012 | WO2012093117A1 Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases |
| 07/12/2012 | WO2012037551A3 Primary cell-derived biologic and wt1 synthetic long peptide vaccine |
| 07/12/2012 | WO2011060290A8 Immediate release tablet formulations |
| 07/12/2012 | US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System |
| 07/12/2012 | US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
| 07/12/2012 | US20120178714 Phosphorus-containing Compounds & Uses Thereof |
| 07/12/2012 | US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 07/12/2012 | US20120177620 Probiotic, Lactic Acid-Producing Bacteria |
| 07/12/2012 | CA2823908A1 Method for selecting patient to be given drug for treating septicemia |
| 07/11/2012 | EP2474323A2 Imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes |
| 07/11/2012 | EP2474315A1 Immunity inducer |
| 07/11/2012 | EP2474307A2 Proliposomal drug delivery system |
| 07/11/2012 | EP2473173A2 Treatment of glaucoma and other retinopathies with gangliosides |
| 07/11/2012 | EP2473167A1 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure. |
| 07/11/2012 | EP2473165A1 Combination medicament |
| 07/11/2012 | EP2473044A1 Tocotrienol compositions |
| 07/11/2012 | EP2473036A1 Antimicrobial compositions and products |
| 07/11/2012 | EP1945265B1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 07/11/2012 | EP1767216B1 Drug having regulatory cell ligand contained in liposome |
| 07/11/2012 | EP1731160B1 Cancer metastasis inhibitory composition |
| 07/11/2012 | EP1487778B1 Substituted 4-aminocyclohexanols |
| 07/11/2012 | EP1131052B1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 07/11/2012 | CN1934255B Combination therapy for the treatment of ocular neovascular disorders |
| 07/11/2012 | CN1822880B Parasiticidal composition |
| 07/11/2012 | CN1762381B Ophthalmic compositions containing galactomannan polymers and borate |
| 07/11/2012 | CN102573911A Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders |
| 07/11/2012 | CN102573867A Compositions for treating degenerative joint diseases |
| 07/11/2012 | CN102573828A Cell protection in dialysis patients by administration of a creatine compound |
| 07/11/2012 | CN102573827A Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases |
| 07/11/2012 | CN102573824A Compositions comprising tramadol and celecoxib in the treatment of pain |
| 07/11/2012 | CN102573813A 持续药物传递系统 Sustained drug delivery system |
| 07/11/2012 | CN102573808A Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 07/11/2012 | CN102573799A Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 07/11/2012 | CN102559720A Expression, purification and crystallization of human coagulation factor XI catalytic structural domain |
| 07/11/2012 | CN102558363A Polypeptide carrier for improving medicament/gene tumor targeting and transfection efficiency and application |
| 07/11/2012 | CN102558334A Peptides that selectively home to heart vasculature and related conjugates and methods |
| 07/11/2012 | CN102558075A Substituted piperazines as CB1 antagonists |
| 07/11/2012 | CN102558070A 用于预防hiv性传播的杀微生物嘧啶或三嗪 Hiv microbicides for the prevention of sexual transmission of pyrimidine or triazine |
| 07/11/2012 | CN102552929A Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide |
| 07/11/2012 | CN102552915A Application of alpha-cyperone serving as natural transdermal absorption enhancer |
| 07/11/2012 | CN102552912A Use of adrenergic beta-3-receptor retardant in tumor resistance |
| 07/11/2012 | CN102552911A Levoamlodipine, aliskiren and sartan compound antihypertensive medicine |
| 07/11/2012 | CN102552910A Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases |
| 07/11/2012 | CN102552909A Composition for treating proteinuria and preparation method for composition |
| 07/11/2012 | CN102552908A Pharmaceutical composition containing artemisinin, artemisinin derivatives and Bcl-2 inhibitor and application thereof |
| 07/11/2012 | CN102552272A Method for treating sepsis |
| 07/11/2012 | CN102552263A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552262A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552261A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552191A Orally disintegrating tablet of 5-HT receptor agonist and preparation method thereof |
| 07/11/2012 | CN102552106A Steroid intraocular implants having an extended sustained release for a period of greater than two months |
| 07/11/2012 | CN101926783B Drug slow control releaser and preparation method thereof |
| 07/11/2012 | CN101905023B Method of effectively using medicine and method concerning prevention of side effect |
| 07/11/2012 | CN101780279B Application of Toll-link receptor-3 agonist to preparation of medicines for promoting wound healing |
| 07/11/2012 | CN101703776B Method for preparing anti-infective agent long-acting injection |
| 07/11/2012 | CN101703473B Polylactic acid-glycollic acid copolymer microspheres and preparation method |
| 07/10/2012 | US8217080 Anti-infective methods and systems for treating pathogen-induced disordered tissues |
| 07/10/2012 | US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/10/2012 | US8217008 Methods of treating inflammatory disease using a soluble IL-20 receptor |
| 07/10/2012 | US8217001 Modification of feeding behavior |
| 07/10/2012 | US8216834 Chimpanzee adenovirus vaccine carriers |
| 07/10/2012 | US8216792 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/10/2012 | US8216776 Dialysate of peritoneal dialysis and its preparation method |
| 07/10/2012 | US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 07/10/2012 | US8216584 Imaging, diagnosis and treatment of disease |
| 07/10/2012 | US8216569 Vascular endothelial growth factor 2 |
| 07/10/2012 | US8216560 Administering a potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic |
| 07/10/2012 | CA2592995C 1-thio-d-glucitol derivatives |
| 07/10/2012 | CA2494832C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 07/10/2012 | CA2486585C Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 07/10/2012 | CA2476730C A photoprotective orally administrable composition for skin |
| 07/10/2012 | CA2475595C Method of reducing and preventing uvb-induced immunosuppression |
| 07/10/2012 | CA2466529C Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
| 07/10/2012 | CA2446356C Use of compositions for treating rosacea |
| 07/10/2012 | CA2444821C Combination therapy using anti-angiogenic agents and tnfa |
| 07/10/2012 | CA2442053C Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 07/10/2012 | CA2440010C Powder inhaler formulations |
| 07/10/2012 | CA2368677C Intramyocardial injection of autologous bone marrow |
| 07/10/2012 | CA2340790C Human il-1 epsilon dna and polypeptides |
| 07/10/2012 | CA2291928C Produits anti-cancereux pour le traitement de la mucoviscidose |
| 07/10/2012 | CA2253664C Methods and devices for providing acoustic hemostasis |
| 07/05/2012 | WO2012092266A1 Serpinin and variants thereof for increasing heart contractility and treating cardiovascular diseases |
| 07/05/2012 | WO2012091571A2 Combination of components for the prevention and treatment of frailty |